nach oben

Reactions Weekly

Erschienen in:

01.03.2023 | Case report

Elexacaftor/ivacaftor/tezacaftor

Systemic arterial hypertension and off-label use: 4 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Auszug

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Gramegna A, et al. Onset of systemic arterial hypertension after initiation of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A case series. Journal of Cystic Fibrosis 21: 885-887, No. 5, Sep 2022. Available from: URL: http://doi.org/10.1016/j.jcf.2022.04.010

Titel: Elexacaftor/ivacaftor/tezacaftor
Systemic arterial hypertension and off-label use: 4 case reports
Publikationsdatum: 01.03.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-34829-9

Multiple drug

Case report

Adalimumab/antibacterials/leflunomide

Case report

Antipsychotics

Case report

Immunosuppressants/ixekizumab

Case report

Calcium hydroxylapatite/cisplatin/vinorelbine

Case report

Tozinameran

Case report

Springer Medizin

Elexacaftor/ivacaftor/tezacaftor

Systemic arterial hypertension and off-label use: 4 case reports

Auszug

Weitere Artikel der Ausgabe 1/2023

Multiple drug

Adalimumab/antibacterials/leflunomide

Antipsychotics

Immunosuppressants/ixekizumab

Calcium hydroxylapatite/cisplatin/vinorelbine

Tozinameran

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Multiple drug

Adalimumab/antibacterials/leflunomide

Antipsychotics

Immunosuppressants/ixekizumab

Calcium hydroxylapatite/cisplatin/vinorelbine

Tozinameran